98 related articles for article (PubMed ID: 22393980)
1. Prognostic impact of risk factors in patients with gastric cancer in Iran.
Roshanaei G; Ghannad MS; Jafarabadi MA; Faradmal J; Sadighi S
Asian Pac J Cancer Prev; 2011; 12(11):3005-8. PubMed ID: 22393980
[TBL] [Abstract][Full Text] [Related]
2. Survival of Patients with Stomach Cancer and its Determinants in Kurdistan.
Moradi G; Karimi K; Esmailnasab N; Roshani D
Asian Pac J Cancer Prev; 2016; 17(7):3243-8. PubMed ID: 27509957
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in gastric cancer using log-normal censored regression model.
Pourhoseingholi MA; Moghimi-Dehkordi B; Safaee A; Hajizadeh E; Solhpour A; Zali MR
Indian J Med Res; 2009 Mar; 129(3):262-7. PubMed ID: 19491418
[TBL] [Abstract][Full Text] [Related]
4. Postoperative life expectancy in gastric cancer patients and its associated factors.
Zeraati H; Mahmoudi M; Kazemnejad A; Mohammed K
Saudi Med J; 2005 Aug; 26(8):1203-7. PubMed ID: 16127513
[TBL] [Abstract][Full Text] [Related]
5. Estimating postoperative survival of gastric cancer patients and factors affecting it in Iran: Based on a TNM-7 Staging System.
Zeraati H; Amiri Z
Acta Med Iran; 2016 Feb; 54(2):114-8. PubMed ID: 26997598
[TBL] [Abstract][Full Text] [Related]
6. Multivariate analysis of prognostic factors in gastric cancer patients using additive hazards regression models.
Maroufizadeh S; Hajizadeh E; Baghestani AR; Fatemi SR
Asian Pac J Cancer Prev; 2011; 12(4):901-7. PubMed ID: 21790223
[TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis of prognostic factors in gastric cancer patients using additive hazards regression models.
Maroufizadeh S; Hajizadeh E; Baghestani AR; Fatemi SR
Asian Pac J Cancer Prev; 2011; 12(7):1697-702. PubMed ID: 22126547
[TBL] [Abstract][Full Text] [Related]
8. Assessment of risk factors affecting recurrence of patients with gastric cancer in the presence of informative censoring in Iran.
Roshanaei G; Kazemnejad A; Sadighi S
Asian Pac J Cancer Prev; 2011; 12(9):2443-6. PubMed ID: 22296398
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
10. Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran.
Samadi F; Babaei M; Yazdanbod A; Fallah M; Nouraie M; Nasrollahzadeh D; Sadjadi A; Derakhshan MH; Shokuhi B; Fuladi R; Malekzadeh R
Arch Iran Med; 2007 Jan; 10(1):32-7. PubMed ID: 17198451
[TBL] [Abstract][Full Text] [Related]
11. Effect of demographic and clinicopathologic factors on prognosis of early gastric cancer in Iran.
Moghimi-Dehkordi B; Safaee A; Pourhoseingholi MA; Zali MR
Asian Pac J Cancer Prev; 2008; 9(4):585-8. PubMed ID: 19256743
[TBL] [Abstract][Full Text] [Related]
12. Prediction of time to recurrence and influencing factors for gastric cancer in Iran.
Roshanaei G; Ghannad MS; Safari M; Sadighi S
Asian Pac J Cancer Prev; 2012; 13(6):2639-42. PubMed ID: 22938434
[TBL] [Abstract][Full Text] [Related]
13. Gastric carcinoma: 5 year experience of a single institute.
Sadighi S; Raafat J; Mohagheghi M; Meemary F
Asian Pac J Cancer Prev; 2005; 6(2):195-6. PubMed ID: 16101332
[TBL] [Abstract][Full Text] [Related]
14. Estimation of hazard function and its associated factors in gastric cancer patients using wavelet and kernel smoothing methods.
Ahmadi A; Roudbari M; Gohari MR; Hosseini B
Asian Pac J Cancer Prev; 2012; 13(11):5643-6. PubMed ID: 23317231
[TBL] [Abstract][Full Text] [Related]
15. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
[TBL] [Abstract][Full Text] [Related]
16. Clinical profile of gastric cancer in Khuzestan, southwest of Iran.
Eskandar H; Hossein SS; Rahim M; Jalal H; Mehrdad A; Rajabi T
World J Gastroenterol; 2006 Aug; 12(30):4832-5. PubMed ID: 16937464
[TBL] [Abstract][Full Text] [Related]
17. [The prognostic analysis of tumor size in T4a stage gastric cancer].
Liu HG; Liang H; Deng JY; Wang L; Liang YX; Jiao XG
Zhonghua Wai Ke Za Zhi; 2013 Mar; 51(3):230-4. PubMed ID: 23859324
[TBL] [Abstract][Full Text] [Related]
18. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
[TBL] [Abstract][Full Text] [Related]
19. Survival analysis of patients with gastric cancer undergoing surgery at the iran cancer institute: a method based on multi-state models.
Zare A; Mahmoodi M; Mohammad K; Zeraati H; Hosseini M; Naieni KH
Asian Pac J Cancer Prev; 2013; 14(11):6369-73. PubMed ID: 24377534
[TBL] [Abstract][Full Text] [Related]
20. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
